NASDAQ:ASLN - ASLAN PHARMACEU/ADR Stock Price, Forecast & News

ASLAN PHARMACEU/ADR's stock was trading at $1.59 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ASLN shares have decreased by 36.8% and is now trading at $1.0050. View which stocks have been mosted impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ASLAN PHARMACEU/ADR in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ASLAN PHARMACEU/ADR.

ASLAN PHARMACEU/ADR is scheduled to release its next quarterly earnings announcement on Monday, May 4th 2020. View our earnings forecast for ASLAN PHARMACEU/ADR.

3 brokers have issued 12-month target prices for ASLAN PHARMACEU/ADR's shares. Their forecasts range from $5.00 to $8.00. On average, they anticipate ASLAN PHARMACEU/ADR's share price to reach $6.33 in the next twelve months. This suggests a possible upside of 530.2% from the stock's current price. View analysts' price targets for ASLAN PHARMACEU/ADR.

Media stories about ASLN stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ASLAN PHARMACEU/ADR earned a daily sentiment score of 1.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutASLAN PHARMACEU/ADR.

Some companies that are related to ASLAN PHARMACEU/ADR include Humanigen (HGEN), MEI Pharma (MEIP), Marinus Pharmaceuticals (MRNS), TAIWAN LIPOSOME/S (TLC), Cerecor (CERC), Evolus (EOLS), Evelo Biosciences (EVLO), Aeglea Bio Therapeutics (AGLE), Fortress Biotech (FBIO), Newron Pharmaceuticals (NWPHF), Paratek Pharmaceuticals (PRTK), Avenue Therapeutics (ATXI), Tyme Technologies (TYME), Kalvista Pharmaceuticals (KALV) and Helix Biopharma (HBPCF).

Based on aggregate information from My MarketBeat watchlists, some companies that other ASLAN PHARMACEU/ADR investors own include Inovio Pharmaceuticals (INO), Actinium Pharmaceuticals (ATNM), Onconova Therapeutics (ONTX), Opko Health (OPK), Sorrento Therapeutics (SRNE), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Cidara Therapeutics (CDTX), Ocugen (OCGN) and Cassava Sciences (SAVA).

(ASLN) raised $60 million in an initial public offering (IPO) on Friday, May 4th 2018. The company issued 7,500,000 shares at $8.05 per share. Leerink Partners and Piper Jaffray acted as the underwriters for the IPO and BTIG, H.C. Wainwright and CLSA were co-managers.

ASLAN PHARMACEU/ADR trades on the NASDAQ under the ticker symbol "ASLN."

ASLAN PHARMACEU/ADR's stock is owned by a variety of institutional and retail investors. Top institutional investors include Marshall Wace LLP (0.30%), Bank of America Corp DE (0.25%), Virtu Financial LLC (0.17%) and Renaissance Technologies LLC (0.05%).

ASLN stock was purchased by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Bank of America Corp DE, Virtu Financial LLC, and Renaissance Technologies LLC.

Shares of ASLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ASLN stock can currently be purchased for approximately $1.01.

ASLAN PHARMACEU/ADR has a market capitalization of $32.21 million and generates $3 million in revenue each year. The company earns $-47,070,000.00 in net income (profit) each year or ($0.74) on an earnings per share basis.  View additional information about ASLAN PHARMACEU/ADR.

The official website for ASLAN PHARMACEU/ADR is http://aslanpharma.com/.

ASLAN PHARMACEU/ADR's mailing address is 83 CLEMENCEAU AVENUE 12-03 UE SQUARE, SINGAPORE U0, 239920. The company can be reached via phone at 65-6222-4235 or via email at [email protected]